PLAINVIEW, N.Y. August 14, 2018 – Vaso Corporation (“Vaso”) (OTCMKTS: VASO) today reported its operating results for the three months ended June 30, 2018. “The Company recorded a total revenue of $18.4 million and $36.0 million for the second quarter and first half of 2018, respectively, representing a growth rate of 3% and 5% from...
Read More

PLAINVIEW, N.Y. May 15, 2018 – Vaso Corporation (“Vaso”) (OTCMKTS: VASO) today reported its operating results for the three months ended March 31, 2018. “The Company’s revenue increased by $1.2 million, or 7%, in the first quarter of 2018 when compared to the same quarter of the prior year, led by a 16% year-over-year quarterly...
Read More

PLAINVIEW, N.Y. May 7, 2018 – Vaso Corporation (“Vaso”) (OTCMKTS: VASO) today announced the appointment of Jane Moen as President of Vaso Diagnostics, Inc. d/b/a/ VasoHealthcare, a wholly owned subsidiary of Vaso Corporation, effective June 1, 2018.  VasoHealthcare has since July 1, 2010 been the exclusive representative for the sale of select GE Healthcare Diagnostic...
Read More

Revenue increased to $72.8 million with 8% Growth in the IT Segment PLAINVIEW, N.Y. March 30, 2018 – Vaso Corporation (“Vaso”) (OTCMKTS: VASO) today reported its operating results for the three months and year ended December 31, 2017. “We are pleased to announce a record revenue of $72.8 million for the fiscal year 2017. This...
Read More

Vaso Corporation Announces Extension of Exclusive Sales Representation Agreement with GE Healthcare Through 2022   Plainview, NY, December 4, 2017 – Vaso Corporation (OTC PK: VASO) (formerly Vasomedical, Inc.) today announces the amendment of the sales representation agreement between its subsidiary, Vaso Diagnostics, Inc. d/b/a VasoHealthcare, and GE Healthcare (“GEHC”), the healthcare business unit of...
Read More